ACCC COVID-19 Resource Center & Discussion Group
for Insights on Providing Optimal Patient Care During the Pandemic.
Providing a VOICE for Minnesota's MULTIDISCIPLINARY CANCER CARE TEAMS and the PATIENTS THEY SERVE since 1992
Meetings & Education
Allied Health Professionals Award
State Society Education Series
MSCO 2020 Fall Conference Highlights
Patient Advocacy Organizations
State & Federal Resources
Financial Advocacy & Patient Assistance
Find A Clinical Trial
National Professional Organizations
Off-Label Use Literature
Become a Corporate Member
Industry News Archive
COVID-19 Featured Resources
NGS Alert for Pegfilgrastim Product Claims
This alert is for all hospital outpatient departments. Pegfilgrastim and biosimilars claims are denying in error due to an internal systems issue in Jurisdiction 6 and Jurisdiction K, Part A outpatient providers. National Government Services (NGS) is in the process of reviewing the cause of the errors and will determine the action it will take.
No provider action is necessary at this time, however, please continue to check the production alerts section of
the NGS website
and future email updates for additional information regarding this issue
If you have any questions, please contact NGS.